Trajectories of the evolution of post COVID-19 condition, up to two years after symptoms onset
Covid19-Sources
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Pedro Lérias on Twitter
Lessons learned from the deadly combination of sepsis and Covid-19
Long COVID: pathophysiological factors and abnormalities of coagulation
Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)
Abwasser-Stalking: Was bringt der Griff ins Klo?
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Intranasal or Intratesticular Route Induces Testicular Damage
Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019
scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells
Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
Temporal Trend in Mortality from COVID‐19 Associated with Cardiovascular Disease
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
Ten COVID Facts Health Officials Dangerously Downplay | The Tyee
Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine
Long Covid: Was wiederholte Ansteckungen für Long Covid bedeuten
153 Mangel an Mannose-bindendes-Lektin (MBL) als Ursache für eine gestörte Erregerabwehr - IMD Institut für medizinische Diagnostik, Labor
Post COVID-19 AA amyloidosis of the kidneys with rapidly progressive renal failure - PubMed
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
SARS-CoV-2 and "Textbook" Immunity
Risk assessment of retinal vascular occlusion after COVID-19 vaccination
Cardiologists Explain Risks of Myocarditis From COVID Vaccines vs Risks of Heart Damage From Infection
Studies have largely confirmed that the overall myocarditis risk is significantly higher after an actual COVID-19 infection compared with vaccination, and that the prognosis following myocarditis due to the vaccine is better than from infection. The specific myocarditis risk varies by age and has been debated because of differing views among a small group of physicians related to risk tolerance and support for or against COVID-19 immunization for specific age groups.
Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents
COVID-19 vaccine appears more effective if received around midday | Washington University School of Medicine in St. Louis
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters
Masks Work. Distorting Science to Dispute the Evidence Doesn’t
Acute and postacute sequelae associated with SARS-CoV-2 reinfection
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 ..
Myocarditis and Pericarditis Following mRNA Vaccination in Ontario, Canada
No Association Between Out-of-Hospital Cardiac Arrest and COVID-19 Vaccination